Ubiquitination events that regulate recombination of immunoglobulin loci gene segments

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Chao, Jaime ^a   Rothschild, Gerson ^a   Basu, Uttiya ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

AID; Class switch recombination; DNA repair; RAG proteins; Somatic hypermutation; Ubiquitination; V(D)J recombination

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; RAG1 PROTEIN; RAG2 PROTEIN; RNA POLYMERASE II; SINGLE STRANDED DNA; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3;

B LYMPHOCYTE; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; MOUSE; MUTAGENESIS; NONHUMAN; PHOSPHORYLATION; REVIEW; SOMATIC HYPERMUTATION; STRUCTURE ANALYSIS; UBIQUITINATION; VDJ RECOMBINATION; WESTERN BLOTTING;

EID: 84897941840     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00100     Document Type: Review

References (73)

1. Alt FW, Zhang Y, Meng FL, Guo C, Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell (2013) 152:417-29. doi:10.1016/j.cell.2013.01.007
2. Bednarski JJ, Sleckman BP. Lymphocyte development: integration of DNA damage response signaling. Adv Immunol (2012) 116:175-204. doi:10.1016/B978-0-12-394300-2.00006-5
3. Schatz DG, Ji Y. Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol (2011) 11:251-63. doi:10.1038/nri2941
4. Keim C, Kazadi D, Rothschild G, Basu U. Regulation of AID, the B-cell genome mutator. Genes Dev (2013) 27:1-17. doi:10.1101/gad.200014.112
5. Xu Z, Zan H, Pone EJ, Mai T, Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol (2012) 12:517-31. doi:10.1038/nri3216
6. Di Noia JM, Neuberger MS. Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem (2007) 76:1-22. doi:10.1146/annurev.biochem.76.061705.090740
7. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem (2012) 81:203-29. doi:10.1146/annurev-biochem-060310-170328
8. Nishana M, Raghavan SC. Role of recombination activating genes in the generation of antigen receptor diversity and beyond. Immunology (2012) 137:271-81. doi:10.1111/imm.12009
9. Swanson PC. The bounty of RAGs: recombination signal complexes and reaction outcomes. Immunol Rev (2004) 200:90-114. doi:10.1111/j.0105-2896.2004.00159.x
10. McMahan CJ, Sadofsky MJ, Schatz DG. Definition of a large region of RAG1 that is important for coimmunoprecipitation of RAG2. J Immunol (1997) 158:2202-10.
11. Jones JM, Gellert M. Autoubiquitylation of the V(D)J recombinase protein RAG1. Proc Natl Acad Sci U S A (2003) 100:15446-51. doi:10.1073/pnas.2637012100
12. Kassmeier MD, Mondal K, Palmer VL, Raval P, Kumar S, Perry GA, et al. VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity. EMBO J (2012) 31:945-58. doi:10.1038/emboj.2011.455
13. Grazini U, Zanardi F, Citterio E, Casola S, Goding CR, McBlane F. The RING domain of RAG1 ubiquitylates histone H3: a novel activity in chromatin-mediated regulation of V(D)J joining. Mol Cell (2010) 37:282-93. doi:10.1016/j.molcel.2009.12.035
14. Simkus C, Bhattacharyya A, Zhou M, Veenstra TD, Jones JM. Correlation between recombinase activating gene 1 ubiquitin ligase activity and V(D)J recombination. Immunology (2009) 128:206-17. doi:10.1111/j.1365-2567.2009.03101.x
15. Jones JM, Bhattacharyya A, Simkus C, Vallieres B, Veenstra TD, Zhou M. The RAG1 V(D)J recombinase/ubiquitin ligase promotes ubiquitylation of acetylated, phosphorylated histone 3.3. Immunol Lett (2011) 136:156-62. doi:10.1016/j.imlet.2011.01.005
16. Yurchenko V, Xue Z, Sadofsky M. The RAG1 N-terminal domain is an E3 ubiquitin ligase. Genes Dev (2003) 17:581-5. doi:10.1101/gad.1058103
17. Schatz DG, Swanson PC. V(D)J recombination: mechanisms of initiation. Annu Rev Genet (2011) 45:167-202. doi:10.1146/annurev-genet-110410-132552
18. Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 97:81-8. doi:10.1182/blood.V97.1.81
19. Simkus C, Anand P, Bhattacharyya A, Jones JM. Biochemical and folding defects in a RAG1 variant associated with Omenn syndrome. J Immunol (2007) 179:8332-40.
20. Simkus C, Makiya M, Jones JM. Karyopherin alpha 1 is a putative substrate of the RAG1 ubiquitin ligase. Mol Immunol (2009) 46:1319-25. doi:10.1016/j.molimm.2008.11.009
21. Lee J, Desiderio S. Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity (1999) 11:771-81. doi:10.1016/S1074-7613(00)80151-X
22. Jiang H, Chang FC, Ross AE, Lee J, Nakayama K, Desiderio S. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol Cell (2005) 18:699-709. doi:10.1016/j.molcel.2005.05.011
23. Mizuta R, Mizuta M, Araki S, Kitamura D. RAG2 is down-regulated by cytoplasmic sequestration and ubiquitin-dependent degradation. J Biol Chem (2002) 277:41423-7. doi:10.1074/jbc.M206605200
24. Jiang H, Chang FC, Ross AE, Lee J, Nakayama K, Nakayama K, et al. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol Cell (2005) 18:699-709. doi:10.1016/j.molcel.2005.05.011
25. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol (2009) 9:767-77. doi:10.1038/nri2656
26. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol (2008) 8:22-33. doi:10.1038/nri2217
27. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, et al. The biochemistry of somatic hypermutation. Annu Rev Immunol (2008) 26:481-511. doi:10.1146/annurev.immunol.26.021607.090236
28. Odegard VH, Schatz DG. Targeting of somatic hypermutation. Nat Rev Immunol (2006) 6:573-83. doi:10.1038/nri1896
29. Di Noia J, Neuberger MS. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature (2002) 419:43-8. doi:10.1038/nature00981
30. Neuberger MS. Antibody diversification by somatic mutation: from Burnet onwards. Immunol Cell Biol (2008) 86:124-32. doi:10.1038/sj.icb.7100160
31. Daniel JA, Nussenzweig A. The AID-induced DNA damage response in chromatin. Mol Cell (2013) 50:309-21. doi:10.1016/j.molcel.2013.04.017
32. Yamane A, Resch W, Kuo N, Kuchen S, Li Z, Sun HW, et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol (2011) 12:62-9. doi:10.1038/ni.1964
33. Shen HM, Tanaka A, Bozek G, Nicolae D, Storb U. Somatic hypermutation and class switch recombination in Msh6(-/-)Ung(-/-) double-knockout mice. J Immunol (2006) 177:5386-92.
34. Neuberger MS, Di Noia JM, Beale RC, Williams GT, Yang Z, Rada C. Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation. Nat Rev Immunol (2005) 5:171-8. doi:10.1038/nri1553
35. Yamane A, Robbiani DF, Resch W, Bothmer A, Nakahashi H, Oliveira T, et al. RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle. Cell Rep (2013) 3:138-47. doi:10.1016/j.celrep.2012.12.006
36. Xue K, Rada C, Neuberger MS. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/-ung-/-mice. J Exp Med (2006) 203:2085-94. doi:10.1084/jem.20061067
37. Aoufouchi S, Faili A, Zober C, D'Orlando O, Weller S, Weill JC, et al. Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med (2008) 205:1357-68. doi:10.1084/jem.20070950
38. Delker RK, Zhou Y, Strikoudis A, Stebbins CE, Papavasiliou FN. Solubility-based genetic screen identifies RING finger protein 126 as an E3 ligase for activation-induced cytidine deaminase. Proc Natl Acad Sci U S A (2013) 110:1029-34. doi:10.1073/pnas.1214538110
39. Pavri R, Nussenzweig MC. AID targeting in antibody diversity. Adv Immunol (2011) 110:1-26. doi:10.1016/B978-0-12-387663-8.00005-3
40. Kenter AL. AID targeting is dependent on RNA polymerase II pausing. Semin Immunol (2012) 24:281-6. doi:10.1016/j.smim.2012.06.001
41. Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet (2012) 13:720-31. doi:10.1038/nrg3293
42. Richard P, Manley JL. Transcription termination by nuclear RNA polymerases. Genes Dev (2009) 23:1247-69. doi:10.1101/gad.1792809
43. Pavri R, Gazumyan A, Jankovic M, Di Virgilio M, Klein I, Ansarah-Sobrinho C, et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell (2010) 143:122-33. doi:10.1016/j.cell.2010.09.017
44. Basu U, Meng FL, Keim C, Grinstein V, Pefanis E, Eccleston J, et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell (2011) 144:353-63. doi:10.1016/j.cell.2011.01.001
45. Wang L, Whang N, Wuerffel R, Kenter AL. AID-dependent histone acetylation is detected in immunoglobulin S regions. J Exp Med (2006) 203:215-26. doi:10.1084/jem.20051774
46. Peters A, Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity (1996) 4:57-65. doi:10.1016/S1074-7613(00)80298-8
47. Klein IA, Resch W, Jankovic M, Oliveira T, Yamane A, Nakahashi H, et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell (2011) 147:95-106. doi:10.1016/j.cell.2011.07.048
48. Sun J, Rothschild G, Pefanis E, Basu U. Transcriptional stalling in B-lymphocytes: a mechanism for antibody diversification and maintenance of genomic integrity. Transcription (2013) 4:127-35. doi:10.4161/trns.24556
49. Sun J, Keim CD, Wang J, Oliver P, Rabadan R, Basu U. E3-ubiquitin ligase Nedd4 determines the fate of AID-associated RNA polymerase II in B cells. Genes Dev (2013) 27:1821-33. doi:10.1101/gad.210211.112
50. Goodarzi AA, Jeggo PA. The repair and signaling responses to DNA double-strand breaks. Adv Genet (2013) 82:1-45. doi:10.1016/B978-0-12-407676-1.00001-9
51. Panier S, Durocher D. Regulatory ubiquitylation in response to DNA double-strand breaks. DNA Repair (Amst) (2009) 8:436-43. doi:10.1016/j.dnarep.2009.01.013
52. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell (2005) 123:1213-26. doi:10.1016/j.cell.2005.09.038
53. Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science (2007) 318:1637-40. doi:10.1126/science.1150034
54. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol (2006) 173:195-206. doi:10.1083/jcb.200510130
55. Al-Hakim A, Escribano-Diaz C, Landry MC, O'Donnell L, Panier S, Szilard RK, et al. The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair (Amst) (2010) 9:1229-40. doi:10.1016/j.dnarep.2010.09.011
56. Durocher D, Henckel J, Fersht AR, Jackson SP. The FHA domain is a modular phosphopeptide recognition motif. Mol Cell (1999) 4:387-94. doi:10.1016/S1097-2765(00)80340-8
57. Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell (2007) 131:887-900. doi:10.1016/j.cell.2007.09.040
58. Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell (2007) 131:901-14. doi:10.1016/j.cell.2007.09.041
59. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell (2006) 127:1361-73. doi:10.1016/j.cell.2006.10.043
60. Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell (2009) 136:435-46. doi:10.1016/j.cell.2008.12.041
61. Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell (2009) 136:420-34. doi:10.1016/j.cell.2008.12.042
62. Mattiroli F, Vissers JH, van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, et al. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell (2012) 150:1182-95. doi:10.1016/j.cell.2012.08.005
63. Panier S, Ichijima Y, Fradet-Turcotte A, Leung CC, Kaustov L, Arrowsmith CH, et al. Tandem protein interaction modules organize the ubiquitin-dependent response to DNA double-strand breaks. Mol Cell (2012) 47:383-95. doi:10.1016/j.molcel.2012.05.045
64. Stolz A, Ertych N, Bastians H. Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin Cancer Res (2011) 17:401-5. doi:10.1158/1078-0432.CCR-10-1215
65. Yamanaka K, Dorjsuren D, Eoff RL, Egli M, Maloney DJ, Jadhav A, et al. A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase kappa. PLoS One (2012) 7:e45032. doi:10.1371/journal.pone.0045032
66. Acs K, Luijsterburg MS, Ackermann L, Salomons FA, Hoppe T, Dantuma NP. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat Struct Mol Biol (2011) 18:1345-50. doi:10.1038/nsmb.2188
67. Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, Mailand N, et al. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat Cell Biol (2011) 13:1376-82. doi:10.1038/ncb2367
68. Reina-San-Martin B, Chen J, Nussenzweig A, Nussenzweig MC. Enhanced intra-switch region recombination during immunoglobulin class switch recombination in 53BP1-/-B cells. Eur J Immunol (2007) 37:235-9. doi:10.1002/eji.200636789
69. Difilippantonio S, Gapud E, Wong N, Huang CY, Mahowald G, Chen HT, et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature (2008) 456:529-33. doi:10.1038/nature07476
70. Bothmer A, Robbiani DF, Di Virgilio M, Bunting SF, Klein IA, Feldhahn N, et al. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol Cell (2011) 42:319-29. doi:10.1016/j.molcel.2011.03.019
71. Dimitrova N, Chen YC, Spector DL, de Lange T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature (2008) 456:524-8. doi:10.1038/nature07433
72. Bunting SF, Callen E, Wong N, Chen HT, Polato F, Gunn A, et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell (2010) 141:243-54. doi:10.1016/j.cell.2010.03.012
73. Bohgaki T, Bohgaki M, Cardoso R, Panier S, Zeegers D, Li L, et al. Genomic instability, defective spermatogenesis, immunodeficiency, and cancer in a mouse model of the RIDDLE syndrome. PLoS Genet (2011) 7:e1001381. doi:10.1371/journal.pgen.1001381